' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

Publikationen

Gewähltes Keyword: botulinum toxin


Diagnosis and Management of Drooling in Children With Progressive Dystonia: A Case Series of Patients With MEGDEL Syndrome
Blommaert, D; van Hulst, K; van den Hoogen, FJA; Erasmus, CE; Wortmann, SB
J CHILD NEUROL. 2016; 31(10): 1220-1226.
Originalarbeiten (Zeitschrift)
New emerging technologies in benign prostatic hyperplasia.
Lusuardi, L; Hruby, S; Janetschek, G;
Curr Opin Urol. 2013; 23(1): 25-29.
Originalarbeiten (Zeitschrift)
A controversy that has been tough to swallow: is the treatment of achalasia now digested?
Roll, GR; Rabl, C; Ciovica, R; Peeva, S; Campos, GM;
J Gastrointest Surg. 2010; 14 Suppl 1: S33-S45.
Originalarbeiten (Zeitschrift)
An open trial of levetiracetam for segmental and generalized dystonia.
Hering, S; Wenning, GK; Seppi, K; Poewe, W; Mueller, J;
Mov Disord. 2007; 22(11):1649-1651
Originalarbeiten (Zeitschrift)
[Drug therapy of female urinary incontinence].
Hampel, C; Gillitzer, R; Pahernik, S; Melchior, SW; Thuroff, JW
Urologe A. 2005; 44(3):244-255
Originalarbeiten (Zeitschrift)
Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin.
Erbguth, FJ;
Mov Disord. 2004; 19 Suppl 8: S2-S6.
Biographical-Items
Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia.
Riccabona, M; Koen, M; Schindler, M; Goedele, B; Pycha, A; Lusuardi, L;
J Urol. 2004; 171(2 Pt 1): 845-848.
Originalarbeiten (Zeitschrift)
Botulinum toxin type B blocks sudomotor function effectively: a 6 month follow up.
Birklein, F; Eisenbarth, G; Erbguth, F; Winterholler, M;
J Invest Dermatol. 2003; 121(6): 1312-1316.
Originalarbeiten (Zeitschrift)
Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin.
Krämer, HH; Angerer, C; Erbguth, F; Schmelz, M; Birklein, F;
J Neurol. 2003; 250(2): 188-193.
Originalarbeiten (Zeitschrift)
A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.
Bakheit, AM; Pittock, S; Moore, AP; Wurker, M; Otto, S; Erbguth, F; Coxon, L;
Eur J Neurol. 2001; 8(6):559-565
Originalarbeiten (Zeitschrift)
Dose thresholds and duration of the local anhidrotic effect of botulinum toxin injections: measured by sudometry.
Braune, C; Erbguth, F; Birklein, F;
Br J Dermatol. 2001; 144(1):111-117
Originalarbeiten (Zeitschrift)
Sudomotor testing discriminates between subjects with and without antibodies against botulinum toxin A--a preliminary observation.
Birklein, F; Erbguth, F;
Mov Disord. 2000; 15(1): 146-149.
Originalarbeiten (Zeitschrift)
Heterotopic ossification in childhood and adolescence
Kluger, G; Kochs, A; Holthausen, H
J CHILD NEUROL. 2000; 15(6): 406-413.
Originalarbeiten (Zeitschrift)
[Protective ptosis by botulinum A toxin injection in corneal affectations].
Gusek-Schneider, GC; Erbguth, F;
Klin Monbl Augenheilkd. 1998; 213(1): 15-22.
Originalarbeiten (Zeitschrift)
Botulinum toxin: influence on respiratory heart rate variation.
Claus, D; Druschky, A; Erbguth, F;
Mov Disord. 1995; 10(5): 574-579.
Originalarbeiten (Zeitschrift)